Efficient correction of Duchenne muscular dystrophy mutations by SpCas9 and dual gRNAs

CRISPR gene therapy is one promising approach for treatment of Duchenne muscular dystrophy (DMD), which is caused by a large spectrum of mutations in the dystrophin gene. To broaden CRISPR gene editing strategies for DMD treatment, we report the efficient restoration of dystrophin expression in indu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Ther Nucleic Acids
Autors principals: Xiang, Xi, Zhao, Xiaoying, Pan, Xiaoguang, Dong, Zhanying, Yu, Jiaying, Li, Siyuan, Liang, Xue, Han, Peng, Qu, Kunli, Jensen, Jonas Brorson, Farup, Jean, Wang, Fei, Petersen, Trine Skov, Bolund, Lars, Teng, Huajing, Lin, Lin, Luo, Yonglun
Format: Artigo
Idioma:Inglês
Publicat: American Society of Gene & Cell Therapy 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039775/
https://ncbi.nlm.nih.gov/pubmed/33868784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2021.03.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars